🇺🇸 FDA
Patent

US 12319657

Solid state crystalline forms of a selective potassium channel modulator

granted A61PA61P25/08

Quick answer

US patent 12319657 (Solid state crystalline forms of a selective potassium channel modulator) held by Xenon Pharmaceuticals Inc. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P25/08